{"id":"arxiv/2601.13714","url":"https://arxiv.org/abs/2601.13714","tags":["q-bio.PE","math.OC"],"score":0,"title":"Cost-Effectiveness of Adult Hepatitis A Vaccination Strategies in Korea Under an Aging Susceptibility Profile","domain":"q-bio.PE","source":"arxiv","authors":["Yuna Lim","Gerardo Chowell","Eunok Jung"],"reviews":0,"subject":"q-bio.PE","summary":"Hepatitis A severity increases sharply with age, while Korea is experiencing a cohort shift in which low seroprevalence adult cohorts are aging into older, higher fatality age groups. This demographic and immunological transition creates an urgent policy question regarding how adult vaccination should be prioritized under resource constraints. We evaluated three adult vaccination scenarios targeting low seroprevalence age groups (S1) 20 to 39 years, (S2) 40 to 59 years, and (S3) 20 to 59 years. Using an age structured dynamic transmission model calibrated to Korean data, we derived…","category":"research","comments":0,"disputed":false,"division":"q-bio","mentions":0,"discussed":0,"published":"2026-01-20","reactions":{}}